Stathopoulos G P, Stergiou G S, Perrea-Kostarelis D N, Dontas I A, Karamanos B G, Karayiannacos P E
Department of Oncology, Hippokration Hospital, Athens, Greece.
Acta Oncol. 1995;34(2):253-6. doi: 10.3109/02841869509093964.
The effect of the cytotoxic drug 5-fluorouracil (5-FU) on plasma lipid levels was studied in patients and animals. Seven patients with metastatic carcinoma of the colon and three with advanced breast cancer were treated with 5-FU monotherapy by i.v. push at a dose of 500 mg/m2/d for 3-5 consecutive days. The animal group comprised 9 rabbits treated with 5-FU by i.v. push at 12-18 mg/kg/d for 2 consecutive days. Measurements of serum lipid levels were performed before and 2 and 4 weeks after 5-FU administration. No obvious change of diet, body weight and bowel habits occurred during the study period. A significant reduction of total plasma cholesterol was observed in both patients and animals. The triglyceride levels were also reduced in the rabbits. Maximal cholesterol-lowering effect was observed in patients and rabbits with higher baseline cholesterol levels. The results suggest that 5-FU might interfere with lipid metabolism.
在患者和动物中研究了细胞毒性药物5-氟尿嘧啶(5-FU)对血浆脂质水平的影响。7例结肠癌转移患者和3例晚期乳腺癌患者接受了5-FU单药治疗,通过静脉推注,剂量为500mg/m²/天,连续3-5天。动物组包括9只兔子,通过静脉推注接受5-FU治疗,剂量为12-18mg/kg/天,连续2天。在5-FU给药前以及给药后2周和4周测量血清脂质水平。研究期间饮食、体重和排便习惯无明显变化。在患者和动物中均观察到血浆总胆固醇显著降低。兔子的甘油三酯水平也降低了。在基线胆固醇水平较高的患者和兔子中观察到最大的降胆固醇效果。结果表明,5-FU可能干扰脂质代谢。